During her doctoral studies Dr. Ochocka-Lewicka studied the role of immune cells in glioma progression at the Nencki Institute of Experimental Biology in Warsaw. She was also engaged in commercial projects on TCR immunotherapies.
Dr. Ochocka-Lewicka was a leader of an NCN Preludium grant. She is also a laureate of the FNP START award and a co-author of 8 publications, including papers in Nature Communications and Cell Reports.
At ICTER, she currently works in the Computational Genomics group as a Postdoctoral Fellow; her position is linked to the OPUS 21 grant.